Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.

MLA

Delitto, Daniel, et al. “Implantation of a Neoantigen-Targeted Hydrogel Vaccine Prevents Recurrence of Pancreatic Adenocarcinoma after Incomplete Resection.” Oncoimmunology, vol. 10, no. 1, Nov. 2021, p. 2001159. EBSCOhost, https://doi.org/10.1080/2162402X.2021.2001159.

APA

Delitto, D., Zabransky, D. J., Chen, F., Thompson, E. D., Zimmerman, J. W., Armstrong, T. D., Leatherman, J. M., Suri, R., Lopez-Vidal, T. Y., Huff, A. L., Lyman, M. R., Guinn, S. R., Baretti, M., Kagohara, L. T., Ho, W. J., Azad, N. S., Burns, W. R., He, J., Wolfgang, C. L., … Jaffee, E. M. (2021). Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection. Oncoimmunology, 10(1), 2001159. https://doi.org/10.1080/2162402X.2021.2001159

Chicago

Delitto, Daniel, Daniel J Zabransky, Fangluo Chen, Elizabeth D Thompson, Jacquelyn W Zimmerman, Todd D Armstrong, James M Leatherman, et al. 2021. “Implantation of a Neoantigen-Targeted Hydrogel Vaccine Prevents Recurrence of Pancreatic Adenocarcinoma after Incomplete Resection.” Oncoimmunology 10 (1): 2001159. doi:10.1080/2162402X.2021.2001159.